Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonistic anti-CD40 antibodies

Antagonistic anti-CD40 antibodies

US Patent 7445780 · Granted Nov 4, 2008

Estimated economic value: $35,976,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ganaxolone for use in treatment of status epilepticus2025
Ganaxolone for use in treatment of status epilepticus2023
Ganaxolone for use in prophylaxis and treatment of postpartum depression2022
Ganaxolone for use in treatment of status epilepticus2021
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies2012
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies2012
Antibodies to stromal cell-derived factor-1 polypeptides2011
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies2010
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies2010
Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof 2010
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies2009
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies2009